0001640334-22-002377.txt : 20221110 0001640334-22-002377.hdr.sgml : 20221110 20221110061107 ACCESSION NUMBER: 0001640334-22-002377 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221109 FILED AS OF DATE: 20221110 DATE AS OF CHANGE: 20221110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liu Lina CENTRAL INDEX KEY: 0001828515 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21320 FILM NUMBER: 221374729 MAIL ADDRESS: STREET 1: MAGNA-LAB, INC. STREET 2: ROOM 105, BUILDING 5, 31 XISHIKU AVENUE CITY: XICHENG DISTRICT, BEIJING STATE: F4 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Yubo International Biotech Ltd CENTRAL INDEX KEY: 0000895464 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 113074326 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ROOM 105, BUILDING 5, 31 XISHIKU AVENUE CITY: BEIJING STATE: F4 ZIP: 00000 BUSINESS PHONE: 86 (010) 6615-5141 MAIL ADDRESS: STREET 1: ROOM 105, BUILDING 5, 31 XISHIKU AVENUE CITY: BEIJING STATE: F4 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: MAGNA LAB INC DATE OF NAME CHANGE: 19940722 4 1 form4.xml FORM 4 X0306 4 2022-11-09-05:00 false 0000895464 Yubo International Biotech Ltd YBGJ 0001828515 Liu Lina ROOM 105, BUILDING 5, XISHIKU AVENUE XICHENG DISTRICT BEIJING F4 00000 CHINA false true false false Chief Financial Officer Class A Common Stock 2022-11-09-05:00 4 S false 4728000 0.50 D 9101400 I By Focus Draw Group Limited The shares of Class A Common Stock are held directly by Focus Draw Group Limited. Ms. Lina Liu is the sole Director of Focus Draw Group Limited, and as such, Ms. Lina Liu may be deemed to have voting and investment power over such shares held by Focus Draw Group Limited. Ms. Lina Liu disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), except to the extent of her indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. /s/ Lina Liu 2022-11-10-05:00